NIH promises Congress the U.S. won't skip safety steps in coronavirus vaccine approval

NIH Director Dr. Francis Collins said studying the safety and effectiveness of Covid-19 vaccine candidates is now the federal agency's "top priority.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.